Loading clinical trials...
Loading clinical trials...
PBA is a neurologic condition that is estimated to impact over a million patients and their families in the United States. PBA occurs secondary to an otherwise unrelated neurologic disease or injury, ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Avanir Pharmaceuticals
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT07033494 · Early Alzheimer's Disease
NCT06159673 · Alzheimer's Disease Psychosis
NCT07225361 · Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
Avanir Pharmaceuticals
Aliso Viejo, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions